数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2021-02-25 2021-02-25 2021-01-19 2020-11-05 2020-08-06 2020-08-06
证券总股本 6337.47 5651.79 6273.79 5648.79 5628.01 5621.56
普通股本 6337.47 5651.79 6273.79 5648.79 5628.01 5621.56
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2021-02-22 2020-12-31 2021-01-19 2020-09-30 2020-08-03 2020-06-30
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2021-02-25 6337.47 未披露 定期报告 2021-02-22
2021-01-19 6273.79 未披露
更多>>
1.Common stock offered by the company 6,250,000 shares of common stock. 2.The number of shares of common stock to be outstanding upon completion of this offering is based on 56,487,891 shares of common stock outstanding as of September 30, 2020.
2021-01-19
2021-02-25 5651.79 未披露
更多>>
From December 31,2019 to December 31,2020 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with at-the-market stock sales, net of issuance costs Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
2020-12-31
2020-11-05 5648.79 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
2020-09-30
2020-08-06 5628.01 未披露 定期报告 2020-08-03
2020-08-06 5621.56 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with at-the-market stock sales, net of issuance costs Issuance of common stock in connection with warrant exercises Issuance of common stock in connection with stock option exercises
2020-06-30
2020-06-22 5507.04 未披露
更多>>
1.Common stock offered by us 6,600,000 shares 2.The number of shares of our common stock to be outstanding upon completion of this offering is based on 48,470,377 shares of our common stock outstanding as of June 15, 2020
2020-06-22
2020-06-17 4847.04 未披露 定期报告 2020-06-15
2020-06-04 4791.94 未披露 定期报告 2020-05-22
2020-05-07 4774.49 未披露 定期报告 2020-05-04
2020-05-07 4771.26 未披露
更多>>
From January 1, 2020 to March 31, 2020 Issuance of common stock in connection with stock option exercises
2020-03-31
2020-03-12 4770.96 未披露 定期报告 2020-03-09
2019-11-05 4763.84 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with private placement with Amgen Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
2019-09-30
2019-09-23 4685.34 未披露 定期报告 2019-09-23
2019-09-18 3935.34 未披露 定期报告 2019-08-31
2019-08-02 3933.73 未披露 定期报告 2019-07-31
2019-08-06 3736.99 未披露
更多>>
From March 31, 2019 to June 30, 2019 Issuance of common stock in connection with stock option exercises
2019-06-30
2019-03-19 3736.16 未披露
更多>>
From December 31, 2017 to December 31, 2018 Issuance of common stock upon conversion of Series A Convertible Redeemable Preferred Stock Issuance of common stock in initial public offering, net of issuance costs Issuance of common stock for stock options exercises
2018-12-31
2018-11-08 3735.16 未披露
更多>>
From December 31, 2017 to September 30, 2018 Issuance of common stock upon conversion of Series A Convertible Redeemable Preferred StockIssuance of common stock in initial public offering, net of issuance costs
2018-09-30
2018-08-13 3735.16 未披露 定期报告 2018-08-09
2018-07-24 3388.20 未披露 定期报告 2018-07-24
2018-05-09 1000.00 1138.20 定期报告 2018-03-31
1.Common stock offered by the company 6,250,000 shares of common stock. 2.The number of shares of common stock to be outstanding upon completion of this offering is based on 56,487,891 shares of common stock outstanding as of September 30, 2020.
From December 31,2019 to December 31,2020 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with at-the-market stock sales, net of issuance costs Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
From June 30, 2020 to September 30, 2020 Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
From March 31, 2020 to June 30, 2020 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with at-the-market stock sales, net of issuance costs Issuance of common stock in connection with warrant exercises Issuance of common stock in connection with stock option exercises
1.Common stock offered by us 6,600,000 shares 2.The number of shares of our common stock to be outstanding upon completion of this offering is based on 48,470,377 shares of our common stock outstanding as of June 15, 2020
From January 1, 2020 to March 31, 2020 Issuance of common stock in connection with stock option exercises
from June 30, 2019 to September 30, 2019 Issuance of common stock in connection with underwritten public offering, net of issuance costs Issuance of common stock in connection with private placement with Amgen Issuance of common stock in connection with stock option exercises Issuance of common stock in connection with warrant exercises
From March 31, 2019 to June 30, 2019 Issuance of common stock in connection with stock option exercises
From December 31, 2017 to December 31, 2018 Issuance of common stock upon conversion of Series A Convertible Redeemable Preferred Stock Issuance of common stock in initial public offering, net of issuance costs Issuance of common stock for stock options exercises
From December 31, 2017 to September 30, 2018 Issuance of common stock upon conversion of Series A Convertible Redeemable Preferred StockIssuance of common stock in initial public offering, net of issuance costs